The Angiogenesis Foundation builds medical advocacy campaigns using sophisticated web platforms, updated social media, and print media dissemination at special events. We create scientific educational content that is accurate, easy to understand, and contains practical information about angiogenesis and its relation to a given disease state and overall health.
Our multimedia campaigns use compelling graphic media that includes:
animations of angiogenesis and antiangiogenesis;
message-based motion graphics;
slide shows containing “Calls to Action”
videos featuring patient or participant testimonials
downloadable brochures for patients and their caregivers
white paper reports based on recent expert summits
references from the peer-reviewed literature; and
links to other resources for information and connections to other advocacy groups.
These tools can be accessed by patients and their caregivers, advocacy leaders, and other stakeholders to help individuals make more informed decisions in their healthcare.
The tools are convertible to materials that can be distributed at live events, such as conference exhibits, and awareness raising events.
Most projects are initially produced in English, with a framework that enables future translation into different languages (for example, Spanish, French, Italian, German, Japanese, Portuguese, etc).
The Science of AMD focuses on increasing international public and patient awareness of wet AMD, the role of angiogenesis in vision loss, and the importance of antiangiogenic treatments for saving vision and keeping a high quality of life for individuals affected by wet AMD worldwide.
The Science of CRC focuses on increasing international public and patient awareness of colorectal cancer (CRC), the role of angiogenesis (new blood vessel growth) in tumor development, and the importance of antiangiogenic treatments for treating CRC and keeping a high quality of life for individuals affected by CRC worldwide.
The Science of DME advocacy campaign focuses on increasing global public awareness of diabetic macular edema (DME), the role of vascular endothelial growth factor (VEGF) in DME, and the benefits of anti-VEGF treatments for patients with DME.
The Science of RVO advocacy campaign provides accurate, easy to understand, and useful information about retinal vein occlusion (RVO), and the evidence supporting anti-VEGF therapy for CRVO. We believe everyone affected by CRVO can be empowered with knowledge of relevant treatments and the practical steps they can take to fight vision loss.
The Eye Can Do It advocacy campaign is a patient-friendly web resource about vision loss for individuals living with diabetes. This educational tool features an
e-book about what to do to protect your vision when diagnosed with diabetes, resources to consult for continued care, and the latest in treatment options. Connect with the Eye Can Do It community on Facebook and Twitter to get the most up-to-date information from The Angiogenesis Foundation regarding news, events, and research development.